Endangerment of the iPSC stock project in Japan: on the ethics of public funding policies

We examined the ethical justification for a national policy governing public funding for the induced pluripotent stem cell (iPSC) stock project in Japan and argue that the initiation of the iPSC stock project in 2012, when no clinical trial using iPSC-derived products had yet succeeded, was prematur...

Descripción completa

Detalles Bibliográficos
Autores principales: Akabayashi, Akira, Nakazawa, Eisuke, Jecker, Nancy S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173809/
https://www.ncbi.nlm.nih.gov/pubmed/30087154
http://dx.doi.org/10.1136/medethics-2018-105024

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173809/
https://www.ncbi.nlm.nih.gov/pubmed/30087154
http://dx.doi.org/10.1136/medethics-2018-105024

Ejemplares similares